SGN-75 in the treatment of patients with CD70-positive malignancies including metastatic renal cell carcinoma.
John A. Thompson
Research Funding - Seattle Genetics; Seattle Genetics
Andres Forero
Research Funding - Seattle Genetics
Elisabeth I. Heath
Research Funding - Seattle Genetics
Sumanta Kumar Pal
Research Funding - Seattle Genetics
Stephen Maxted Ansell
Research Funding - Seattle Genetics
Jeffrey R. Infante
Research Funding - Seattle Genetics
Sven De Vos
Consultant or Advisory Role - Seattle Genetics
Research Funding - Seattle Genetics
Paul A. Hamlin
Consultant or Advisory Role - Seattle Genetics
Research Funding - Seattle Genetics
Nancy Cherry Whiting
Employment or Leadership Position - Seattle Genetics
Stock Ownership - Seattle Genetics
Baiteng Zhao
Employment or Leadership Position - Seattle Genetics
Stock Ownership - Seattle Genetics
Nizar M. Tannir
Research Funding - Seattle Genetics